J. Pache

1000 total citations
9 papers, 640 citations indexed

About

J. Pache is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, J. Pache has authored 9 papers receiving a total of 640 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 6 papers in Cardiology and Cardiovascular Medicine and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in J. Pache's work include Coronary Interventions and Diagnostics (8 papers), Antiplatelet Therapy and Cardiovascular Diseases (5 papers) and Cerebrovascular and Carotid Artery Diseases (4 papers). J. Pache is often cited by papers focused on Coronary Interventions and Diagnostics (8 papers), Antiplatelet Therapy and Cardiovascular Diseases (5 papers) and Cerebrovascular and Carotid Artery Diseases (4 papers). J. Pache collaborates with scholars based in Germany, Netherlands and United States. J. Pache's co-authors include Julinda Mehilli, Adnan Kastrati, Albert Schömig, S. Schulz, Robert A. Byrne, Melchior Seyfarth, Raisuke Iijima, Rainer Wessely, Olga Bruskina and Steffen Maßberg and has published in prestigious journals such as Journal of the American College of Cardiology, European Heart Journal and Journal of Internal Medicine.

In The Last Decade

J. Pache

9 papers receiving 603 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Pache Germany 8 551 484 215 95 41 9 640
Paolo Zocca Netherlands 14 584 1.1× 521 1.1× 144 0.7× 96 1.0× 14 0.3× 37 673
Girish Mood United States 6 435 0.8× 359 0.7× 108 0.5× 103 1.1× 18 0.4× 8 502
Hans Störger Germany 11 428 0.8× 305 0.6× 152 0.7× 217 2.3× 8 0.2× 36 511
Marinella Centemero Brazil 11 580 1.1× 433 0.9× 180 0.8× 241 2.5× 11 0.3× 59 674
J. W. Louwerenburg Netherlands 12 681 1.2× 583 1.2× 185 0.9× 211 2.2× 6 0.1× 23 762
Manuel Gómez-Recio Spain 6 266 0.5× 191 0.4× 118 0.5× 104 1.1× 18 0.4× 11 342
Renata Rogacka Italy 10 479 0.9× 399 0.8× 115 0.5× 253 2.7× 22 0.5× 14 538
Simon Eccleshall United Kingdom 14 623 1.1× 530 1.1× 282 1.3× 265 2.8× 65 1.6× 53 810
Seung-Jung Park South Korea 11 566 1.0× 501 1.0× 214 1.0× 235 2.5× 50 1.2× 15 707
Fusako Oshima Japan 2 363 0.7× 251 0.5× 142 0.7× 93 1.0× 15 0.4× 2 389

Countries citing papers authored by J. Pache

Since Specialization
Citations

This map shows the geographic impact of J. Pache's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Pache with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Pache more than expected).

Fields of papers citing papers by J. Pache

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Pache. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Pache. The network helps show where J. Pache may publish in the future.

Co-authorship network of co-authors of J. Pache

This figure shows the co-authorship network connecting the top 25 collaborators of J. Pache. A scholar is included among the top collaborators of J. Pache based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Pache. J. Pache is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Schulz, S., Julinda Mehilli, F.-J. Neumann, et al.. (2010). ISAR-REACT 3A: a study of reduced dose of unfractionated heparin in biomarker negative patients undergoing percutaneous coronary intervention. European Heart Journal. 31(20). 2482–2491. 52 indexed citations
3.
Byrne, Robert A., Julinda Mehilli, Raisuke Iijima, et al.. (2008). A polymer-free dual drug-eluting stent in patients with coronary artery disease: a randomized trial vs. polymer-based drug-eluting stents. European Heart Journal. 30(8). 923–931. 111 indexed citations
4.
Mehilli, Julinda, Robert A. Byrne, Aleksandra Wieczorek, et al.. (2008). Randomized trial of three rapamycin-eluting stents with different coating strategies for the reduction of coronary restenosis. European Heart Journal. 29(16). 1975–1982. 143 indexed citations
6.
Wessely, Rainer, et al.. (2007). Randomized trial of rapamycin- and paclitaxel-eluting stents with identical biodegradable polymeric coating and design. European Heart Journal. 28(22). 2720–2725. 23 indexed citations
7.
Hausleiter, Jörg, Adnan Kastrati, Julinda Mehilli, et al.. (2004). A randomized trial comparing phosphorylcholine‐coated stenting with balloon angioplasty as well as abciximab with placebo for restenosis reduction in small coronary arteries. Journal of Internal Medicine. 256(5). 388–397. 52 indexed citations
8.
Pache, J., Adnan Kastrati, & Julinda Mehilli. (2003). Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial. ACC Current Journal Review. 12(4). 66–66. 64 indexed citations
9.
Hausleiter, Jörg, Josef Dirschinger, Helmut Schühlen, et al.. (1998). A multicenter randomized trial comparing five different types of slotted-tube stents. Journal of the American College of Cardiology. 31. 80–80. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026